Certific and PocDoc collaborate to tackle cardiovascular disease

Healthtech startups announce a partnership to tackle world’s biggest killer with novel screening and remote monitoring.

Hot on the heels of its €7.4 million raise to accelerate remote medical diagnostics, Certific has announced it is partnering with healthtech startup PocDoc to tackle the world’s biggest killer – cardiovascular disease.

The novel screening will allow patients to remotely monitor blood pressure, BMI and, crucially, quantitative lipid levels through the same user experience. This solution will be rolled out through a number of pilots, in conjunction with the NHS, across the UK, and eventually across Europe and globally.

Longevity.Technology: Heart and circulatory diseases cause a quarter of all deaths in the UK – that’s more than 160,000 deaths each year, or one every three minutes. There are around 7.6 million people living with a heart or circulatory disease in the UK. This costs the country’s National Health Service (NHS) an estimated £7.4 billion per year, with a wider cost to the economy of around £15.8 billion. Early identification of those at highest risk can ensure appropriate treatment, prevent many cases and reduce the strain on the healthcare system.

Certific and PocDoc are combining their expertise with the aim of leading the revolution in self-directed healthcare. PocDoc’s unique and ground-breaking technology allows anyone with a smartphone to give themselves an accurate ‘at home’ blood test for major diseases, including cardiovascular disease and diabetes. Certific enables certified remote medical diagnostics at scale by providing technology that makes self-administered medical tests reliable, straightforward and easy to do anywhere, making it more convenient for the patient and saving time and money for healthcare professionals.

Steve Roest, CEO of PocDoc, said: “We are delighted to announce PocDoc’s partnership with Certific – they are a real digital disruptor in healthcare that we admire and have followed their success closely. They bring a wealth of experience and our combined knowledge will empower patients to improve their heart health, helping prevent future heart attacks or strokes through home-based digital solutions.’’

Photograph: Certific

Liis Narusk, Co-Founder & CEO of Certific, commented: “This collaboration is a strong step forward in Certific’s mission of providing pioneering and scalable technology that enables self-testing for multiple conditions, radically improving the cost and convenience for patients and healthcare providers alike. Adding PocDoc’s expertise in cardiovascular screening enables Certific to expand its portfolio of certified medical diagnostics and tackle a disease that is a leading cause of disability and death in the UK and around the world.’’

PocDoc is an NHS Digital Health Accelerator backed healthtech company that recently announced its first in-house test for the gold-standard 5 marker lipid panel. Backed by major investors including MMC Ventures, Forward Partners and the founder of healthtech unicorn Ada Health, PocDoc won the MedTech Breakthrough Award 2022 and has also won multiple Innovate UK awards. The company has a number of key partnerships, including Dears Pharmacy, a major chain of independent pharmacies in Scotland with access to over 500,000 patients per year and PATH, a global NGO to help aid the eradication of polio.

Certific‘s purpose is to bring medical services closer to people by making them radically easier, cheaper and more accessible. The company’s platform uses technology that guides patients to perform simple procedures without the need for medical professionals. In July of this year, the startup raised €7.4 million of investment to advance remote medical diagnostics led by Plural and backed by Specialist VC and angel investors such as Christopher North, former UK MD of Amazon. The funding is set to drive Certific’s product expansion and entry into new markets.

Photograph: Certific